This community is composed of technical experts who have decades of experience in topics ranging from drug substance manufacture and solid form selection to drug product at feasibility to commercial scales. Each of our Subject Matter Experts have extensive experience in one or more of the following areas: Drug Substance/API, Bioavailability Enhancement, First-in-Human, Solid Form Selection, Dosage Forms/Multiparticulates, Inhalation, Mammalian Expression Systems, and Microbial Expression Systems.